|
1
|
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction.
|
Circ Res
|
2007
|
2.69
|
|
2
|
TGF-beta1 induces efficient differentiation of human cardiomyocyte progenitor cells into functional cardiomyocytes in vitro.
|
Stem Cell Res
|
2008
|
1.98
|
|
3
|
Human relevance of pre-clinical studies in stem cell therapy: systematic review and meta-analysis of large animal models of ischaemic heart disease.
|
Cardiovasc Res
|
2011
|
1.85
|
|
4
|
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.
|
Cardiovasc Res
|
2013
|
1.72
|
|
5
|
Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.
|
Circulation
|
2007
|
1.61
|
|
6
|
In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions.
|
Circulation
|
2002
|
1.61
|
|
7
|
Necrostatin-1 alleviates reperfusion injury following acute myocardial infarction in pigs.
|
Eur J Clin Invest
|
2015
|
1.45
|
|
8
|
MicroRNA-100 regulates neovascularization by suppression of mammalian target of rapamycin in endothelial and vascular smooth muscle cells.
|
Circulation
|
2011
|
1.38
|
|
9
|
Inhibition of RIP1-dependent necrosis prevents adverse cardiac remodeling after myocardial ischemia-reperfusion in vivo.
|
Basic Res Cardiol
|
2012
|
1.30
|
|
10
|
MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells.
|
J Mol Cell Cardiol
|
2012
|
1.20
|
|
11
|
Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs.
|
EMBO Mol Med
|
2012
|
1.20
|
|
12
|
MicroRNA-214 inhibits angiogenesis by targeting Quaking and reducing angiogenic growth factor release.
|
Cardiovasc Res
|
2012
|
1.18
|
|
13
|
MicroRNA-155 prevents necrotic cell death in human cardiomyocyte progenitor cells via targeting RIP1.
|
J Cell Mol Med
|
2010
|
1.13
|
|
14
|
Isolation and expansion of resident cardiac progenitor cells.
|
Expert Rev Cardiovasc Ther
|
2007
|
1.08
|
|
15
|
Concise review: heart regeneration and the role of cardiac stem cells.
|
Stem Cells Transl Med
|
2013
|
1.08
|
|
16
|
Active Wnt signaling in response to cardiac injury.
|
Basic Res Cardiol
|
2010
|
1.06
|
|
17
|
Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells.
|
Biomaterials
|
2011
|
1.03
|
|
18
|
Cardiospheres and tissue engineering for myocardial regeneration: potential for clinical application.
|
J Cell Mol Med
|
2010
|
1.00
|
|
19
|
Balance between angiopoietin-1 and angiopoietin-2 is in favor of angiopoietin-2 in atherosclerotic plaques with high microvessel density.
|
J Vasc Res
|
2008
|
0.98
|
|
20
|
Human cardiomyocyte progenitor cell-derived cardiomyocytes display a maturated electrical phenotype.
|
J Mol Cell Cardiol
|
2009
|
0.98
|
|
21
|
Transendocardial cell injection is not superior to intracoronary infusion in a porcine model of ischaemic cardiomyopathy: a study on delivery efficiency.
|
J Cell Mol Med
|
2012
|
0.96
|
|
22
|
Targeting cell death in the reperfused heart: pharmacological approaches for cardioprotection.
|
Int J Cardiol
|
2012
|
0.94
|
|
23
|
A fast pH-switchable and self-healing supramolecular hydrogel carrier for guided, local catheter injection in the infarcted myocardium.
|
Adv Healthc Mater
|
2013
|
0.94
|
|
24
|
Sustained delivery of insulin-like growth factor-1/hepatocyte growth factor stimulates endogenous cardiac repair in the chronic infarcted pig heart.
|
J Cardiovasc Transl Res
|
2014
|
0.93
|
|
25
|
Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges.
|
Clin Sci (Lond)
|
2014
|
0.90
|
|
26
|
Increased expression of the transforming growth factor-beta signaling pathway, endoglin, and early growth response-1 in stable plaques.
|
Stroke
|
2008
|
0.90
|
|
27
|
Advanced measurement techniques of regional myocardial function to assess the effects of cardiac regenerative therapy in different models of ischaemic cardiomyopathy.
|
Eur Heart J Cardiovasc Imaging
|
2012
|
0.90
|
|
28
|
Impaired recruitment of HHT-1 mononuclear cells to the ischaemic heart is due to an altered CXCR4/CD26 balance.
|
Cardiovasc Res
|
2009
|
0.88
|
|
29
|
Increased arterial expression of a glycosylated haptoglobin isoform after balloon dilation.
|
Cardiovasc Res
|
2003
|
0.88
|
|
30
|
Cell therapy for myocardial regeneration.
|
Curr Mol Med
|
2009
|
0.87
|
|
31
|
MiR-155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPCs) via targeting of MMP-16.
|
J Cell Mol Med
|
2012
|
0.86
|
|
32
|
Wnt/β-catenin signaling directs the regional expansion of first and second heart field-derived ventricular cardiomyocytes.
|
Development
|
2013
|
0.86
|
|
33
|
Hyperpolarization induces differentiation in human cardiomyocyte progenitor cells.
|
Stem Cell Rev
|
2010
|
0.84
|
|
34
|
Non-surgical stem cell delivery strategies and in vivo cell tracking to injured myocardium.
|
Int J Cardiovasc Imaging
|
2010
|
0.83
|
|
35
|
Cardiac allograft vasculopathy: a donor or recipient induced pathology?
|
J Cardiovasc Transl Res
|
2015
|
0.83
|
|
36
|
Different types of cultured human adult cardiac progenitor cells have a high degree of transcriptome similarity.
|
J Cell Mol Med
|
2014
|
0.83
|
|
37
|
Foetal and adult cardiomyocyte progenitor cells have different developmental potential.
|
J Cell Mol Med
|
2010
|
0.82
|
|
38
|
Concise review: Engineering myocardial tissue: the convergence of stem cells biology and tissue engineering technology.
|
Stem Cells
|
2013
|
0.81
|
|
39
|
Stem cells from in- or outside of the heart: isolation, characterization, and potential for myocardial tissue regeneration.
|
Pediatr Cardiol
|
2009
|
0.81
|
|
40
|
Cardiac-Derived Extracellular Matrix Enhances Cardiogenic Properties of Human Cardiac Progenitor Cells.
|
Cell Transplant
|
2015
|
0.81
|
|
41
|
Environmental regulation of valvulogenesis: implications for tissue engineering.
|
Eur J Cardiothorac Surg
|
2010
|
0.80
|
|
42
|
Post-transcriptional regulation of α-1-antichymotrypsin by microRNA-137 in chronic heart failure and mechanical support.
|
Circ Heart Fail
|
2013
|
0.80
|
|
43
|
The potential of modulating small RNA activity in vivo.
|
Mini Rev Med Chem
|
2009
|
0.79
|
|
44
|
Sequential use of human-derived medium supplements favours cardiovascular tissue engineering.
|
J Cell Mol Med
|
2012
|
0.78
|
|
45
|
Decreased mechanical properties of heart valve tissue constructs cultured in platelet lysate as compared to fetal bovine serum.
|
Tissue Eng Part C Methods
|
2011
|
0.77
|
|
46
|
Stem Cell Aging and Age-Related Cardiovascular Disease: Perspectives of Treatment by Ex-vivo Stem Cell Rejuvenation.
|
Curr Drug Targets
|
2015
|
0.77
|
|
47
|
Increasing short-term cardiomyocyte progenitor cell (CMPC) survival by necrostatin-1 did not further preserve cardiac function.
|
Cardiovasc Res
|
2013
|
0.77
|
|
48
|
Expanding mouse ventricular cardiomyocytes through GSK-3 inhibition.
|
Curr Protoc Cell Biol
|
2013
|
0.76
|
|
49
|
Platelet-lysate as an autologous alternative for fetal bovine serum in cardiovascular tissue engineering.
|
Tissue Eng Part A
|
2010
|
0.76
|
|
50
|
Human cardiomyocyte progenitor cells: a short history of nearly everything.
|
J Cell Mol Med
|
2012
|
0.75
|
|
51
|
Corrigendum: Gap junctional protein Cx43 is involved in the communication between extracellular vesicles and mammalian cells.
|
Sci Rep
|
2015
|
0.75
|
|
52
|
MicroRNA Therapeutics for Cardiac Regeneration.
|
Mini Rev Med Chem
|
2015
|
0.75
|